COMMUNIQUÉS West-GlobeNewswire

Rectify Pharmaceuticals Presents Discovery of Clinical Candidate RTY-406, a Novel Disease-Modifying Therapy for the Treatment of PSC at ACS Fall 2026 Meeting
27/08/2026
Presentation highlights the discovery and characterization of RTY-406, an oral, once-daily investigational therapy targeting the underlying drivers of disease in Primary Sclerosing Cholangitis (PSC) BOSTON, Aug. 27, [...]
SL Science Highlights New FDA Drug Master File for GDT Cell-Derived Exosomes, Expanding the Regulatory Foundation of its Platform
27/08/2026
TAIPEI, Taiwan, Aug. 27, 2026 (GLOBE NEWSWIRE) -- SL Science Holding Limited (“SL Science” or the “Company”) (NASDAQ: SLBT), a Taiwan-headquartered biomedical company specializing in innovative cellular and gene [...]
Artelo Biosciences Announces Reverse Stock Split
27/08/2026
Shares Expected to Begin Trading on a Split-Adjusted Basis on August 31, 2026 SOLANA BEACH, Calif., Aug. 27, 2026 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL) (“Artelo” or the “Company”), a clinical-stage [...]
CytomX Therapeutics Announces FDA Fast Track Designation for Varsetatug masetecan (“Varseta-M”) for Relapsed/Refractory Metastatic Colorectal Cancer (R/R mCRC)
27/08/2026
- Fast Track Designation follows encouraging Phase 1 data that were previously reported for R/R mCRC - - Potential Varseta-M monotherapy registrational study in R/R mCRC planned for initiation in 1H 2027 - SOUTH SAN [...]
MBX Biosciences Announces First Patient Dosed in Pivotal Phase 3 oPTimize Trial of Once-Weekly Canvuparatide in Adults with Hypoparathyroidism
27/08/2026
Pivotal Phase 3 oPTimize trial design builds on positive Phase 2 Avail™ results and durable one-year clinical benefit Global registrational trial to enroll approximately 160 adults with HP to support once-weekly [...]
Noah Medical Announces Collaboration to Advance Imaging in Robotic-Assisted Bronchoscopy
27/08/2026
Compatibility between the Galaxy™ System and premium GE HealthCare OEC C-arms reflects collaboration to expand access to advanced lung diagnostics SAN JOSE, Calif., Aug. 27, 2026 (GLOBE NEWSWIRE) -- Noah Medical today [...]
Cardurion Pharmaceuticals Announces Late-Breaking Presentation of Phase 2 Results for Tovinontrine (CRD-750), a PDE9 Inhibitor, in Heart Failure
27/08/2026
Results from two Phase 2 clinical trials assessing tovinontrine in both major types of chronic heart failure will be presented at the Heart Failure Society of America annual scientific meeting BURLINGTON, Mass., Aug. 27 [...]
HealthEquity Reports Second Quarter Ended July 31, 2026 Financial Results
27/08/2026
Highlights of the second quarter include: Net income increased 10% to $65.6 million , and net income margin increased to 19% from 18% last year. Adjusted EBITDA increased 11% to $167.0 million , and Adjusted EBITDA [...]
Milestone Pharmaceuticals Announces Data Presented at ESC Congress 2026 on the Impact of Paroxysmal Supraventricular Tachycardia (PSVT) on Patients’ Daily Lives and Quality of Life Between Episodes
27/08/2026
Research Shows that Patients with PSVT Experience a Substantial Burden Between Episodes, with Negative Impacts on Anxiety, Daily Activities, Sleep, and Work MONTREAL and CHARLOTTE, N.C., Aug. 27, 2026 (GLOBE NEWSWIRE [...]
Verrica Pharmaceuticals Announces Completion of Enrollment in First Pivotal Phase 3 Trial (COVE-2) Evaluating YCANTH® for the Treatment of Common Warts, with Topline Data Expected Q1 2027
27/08/2026
– Per-protocol interim statistical power analysis confirms no additional patients are recommended for full enrollment – – Second pivotal Phase 3 trial (COVE-3) has already exceeded 50% of current target enrollment, with [...]
Pluri Announces Pricing of $3.3 Million Registered Direct Offering and Concurrent Private Placement with a Single Healthcare Focused Institutional Investor
27/08/2026
HAIFA, Israel, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Pluri Inc. (Nasdaq: PLUR) (TASE: PLUR) (“Pluri”), a biotechnology company, leveraging its proprietary three-dimensional ("3D") cell expansion platform across two [...]
Entera to Participate in Upcoming Fall Investor Conferences
27/08/2026
TEL AVIV, Israel, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX) (“Entera” or the “Company”), a leader in the development of oral peptides, today announced that the Company’s Chief Executive Officer, [...]
Eascra Biotech Appoints Chief Scientific Officer to Lead Commercialization Push
27/08/2026
Veteran biotherapeutics and genetic medicines leader joins nanomedicine startup to drive commercialization and pharma partnerships BOSTON, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Eascra Biotech , a nanomedicine startup, with [...]
Myriad Genetics to Present at 2026 Wells Fargo Healthcare Conference
27/08/2026
SALT LAKE CITY, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc . (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announces Myriad management will present at the 21 st [...]
Philips and Imricor launch cardiac interventional MR lab solution, expanding longstanding collaboration
27/08/2026
August 27, 2026 The solution combines Philips' high-performance 1.5T MRI platform and advanced interventional workflow capabilities with Imrico r' s exclusive portfolio of systems and consumables for MR-guided cardiac [...]
POSSIBLE® by Standard Process® Launches Peanut Butter Banana Cacao Snack Bar
27/08/2026
A Whole Food Snack Bar Designed to Support Real Life PALMYRA, Wis., Aug. 27, 2026 (GLOBE NEWSWIRE) -- POSSIBLE ® by Standard Process ® today announced the launch of its new POSSIBLE ® Peanut Butter Banana Cacao Snack [...]
AIM ImmunoTech Participates in the Virtual Investor ‘Why Now’ On-Demand Conference
27/08/2026
Video webcast now available here OCALA, Fla., Aug. 27, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that it participated in the Virtual Investor "Why Now" on [...]
Daré Bioscience CEO, Sabrina Martucci Johnson, Participates in the Virtual Investor “Why Now” On-Demand Series
27/08/2026
Video webcast now available here SAN DIEGO, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a purpose-driven health biotech company solely focused on closing the gap in women's health between [...]
Outlook Therapeutics CEO, Bob Jahr, Participates in the Virtual Investor “Why Now” On-Demand Conference
27/08/2026
Video webcast now available here ISELIN, N.J., Aug. 27, 2026 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on the development and commercialization of LYTENAVA™ ( [...]

Pages